
Biotec Pharmacon Asa (0DRV)
LSE
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
Return on Assets (%) | -33.81 | -19.422 | -7.88 | 55.501 | 18.331 | 10.896 | 5.901 | 2.215 |
Return on Equity (%) | -44.177 | -29.178 | -12.908 | 68.465 | 21.026 | 12.41 | 6.54 | 2.394 |
Return on Invested Capital (%) | -42.792 | -22.32 | -7.723 | 79.774 | 23.975 | 11.071 | 3.825 | -0.296 |
Operating Margin (%) | -36.152 | -19.699 | -6.622 | 36.678 | 46.845 | 31.267 | 21.239 | 10.245 |
Net Profit Margin (%) | -37.396 | -21.257 | -8.267 | 58.096 | 36.243 | 23.99 | 16.332 | 7.256 |
Book Value Per Share | 0.858 | 0.929 | 0.948 | 4.053 | 4.825 | 5.448 | 5.567 | 8.529 |
Earnings Per Share | -0.567 | -0.294 | -0.132 | 1.72 | 0.921 | 0.65 | 0.382 | 0.223 |
Cash Per Share | 0.696 | 0.655 | 0.647 | 2.9 | 3.979 | 4.828 | 3.511 | 5.026 |
Working Capital Per Share | 0.753 | 0.798 | 0.682 | 3.285 | 4.142 | 4.85 | 5.079 | 7.899 |
Operating Profit Per Share | 1.157 | 1.106 | 1.355 | 2.601 | 2.525 | 2.62 | 2.236 | 3.002 |
EBIT Per Share | -0.564 | -0.29 | -0.123 | 1.071 | 1.171 | 0.833 | 0.487 | 0.314 |
EBITDA Per Share | -0.564 | -0.29 | -0.123 | 1.071 | 1.171 | 0.833 | 0.487 | 0.314 |
Free Cash Flow Per Share | -0.498 | -0.335 | -0.215 | 1.553 | 1.088 | 0.796 | 0.634 | 0.309 |
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 43,95M | 48,34M | 48,34M | 48,34M | 50,37M | 50,57M | 50,87M | N/A |
Capitalisation boursière | 224,49M |
Ratio cours/bénéfice | 29,65 |
Ratio prix/ventes | 2,08 |
Ratio prix/liquidités | 1,31 |
Ratio prix/valeur comptable | 0,69 |
Rendement de dividende | - |
Actions en circulation | 34,01M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 21 |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 6,60 |
Plus bas sur 52 semaines | 6,60 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales